Aquestive Therapeutics, Inc. (AQST) vs Emergent Biosolutions Inc. (EBS)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
Aquestive Therapeutics, Inc. and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $509.6M against $368.1M — 1.4× the size. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against −9.56%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −144.6%) and the lower return on invested capital (−5.27% vs 0.00%). Across the 18 metrics below, Aquestive Therapeutics, Inc. leads on 10 and Emergent Biosolutions Inc. on 8.
Valuation
Profitability
| Metric | AQST | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 55.87% | 53.94% |
| Operating margin | (97.52%) | (8.57%) | 0.00% |
| Net margin | (144.63%) | (22.96%) | 0.00% |
| Free cash flow margin | (84.95%) | 11.18% | 0.00% |
| Return on equity | 121.12% | (40.29%) | (0.40%) |
| Return on assets | (69.29%) | (13.95%) | (3.32%) |
| Return on invested capital | 0.00% | (5.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack